active: true
branding:
    icon_url: https://api.polygon.io/v1/reference/company-branding/YXNjZW5kaXNwaGFybWEuY29t/images/2025-04-04_icon.jpeg
    logo_url: https://api.polygon.io/v1/reference/company-branding/YXNjZW5kaXNwaGFybWEuY29t/images/2025-04-04_logo.png
cik: '0001612042'
composite_figi: BBG007R7VNC1
currency_name: usd
description: Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon
    technology platform to make a meaningful difference for patients. The firm's product
    pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon
    CNP, and others. It operates in North America, Europe, and Rest of the world and
    derives the majority of its revenue from North America.
homepage_url: https://www.ascendispharma.com
list_date: '2015-01-28'
locale: us
market: stocks
market_cap: 11570736280.640001
name: Ascendis Pharma A/S American Depositary Shares
primary_exchange: XNAS
round_lot: 100
share_class_figi: BBG007R7VP72
share_class_shares_outstanding: 61151463
ticker: ASND
ticker_root: ASND
total_employees: 1017
type: ADRC
weighted_shares_outstanding: 60554408
